Publications by authors named "E Goarant"

Claim this Profile
D
Duration of nivolumab for pretreated, advanced non-small-cell lung cancer.
Margaux Geier, Renaud Descourt, Romain Corre, Guillaume Léveiller, Régine Lamy, Éric Goarant

Cancer Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line pembrolizumab for non-small cell lung cancer patients with PD-L1 ≥50% in a multicenter real-life cohort: The PEMBREIZH study.
Karim Amrane, Margaux Geier, Romain Corre, Hervé Léna, Guillaume Léveiller, Eric Goarant

Cancer Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of distance from surgery department on the outcome of patients followed for non-small-cell lung cancer in the respiratory department of nonacademic hospitals: Results of the KBP-2010-study.
Didier Debieuvre, Gislaine Fraboulet, Bernard Duvert, Jacques Piquet, Eric Goarant

Bull Cancer· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[One-year survival improvement in lung cancer in France. Results of the prospective real life studies KBP-2000-CPHG and KBP-2010-CPHG].
M Grivaux, B Duvert, P Ferrer-Lopez, S Hominal, E Goarant

Rev Pneumol Clin· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year survival for lung cancer patients managed in general hospitals.
M Grivaux, M Zureik, L Marsal, B Asselain, M Peureux, E Goarant

Rev Mal Respir· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis